Advertisement
U.S. Markets closed

BioInvent International AB (publ) (0H22.IL)

IOB - IOB Delayed Price. Currency in SEK
45.10+0.38 (+0.84%)
At close: 10:10AM GMT
Currency in SEK

Valuation Measures4

Market Cap (intraday) 2.86B
Enterprise Value 1.93B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)73.97
Price/Book (mrq)2.85
Enterprise Value/Revenue 53.34
Enterprise Value/EBITDA -20.59

Trading Information

Stock Price History

Beta (5Y Monthly) 0.28
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 348.90
52 Week Low 30.00
50-Day Moving Average 343.90
200-Day Moving Average 331.32

Share Statistics

Avg Vol (3 month) 3497
Avg Vol (10 day) 310
Shares Outstanding 565.8M
Implied Shares Outstanding 6N/A
Float 834.14M
% Held by Insiders 111.10%
% Held by Institutions 154.83%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Dec 14, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Jun 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-479.58%

Management Effectiveness

Return on Assets (ttm)-12.90%
Return on Equity (ttm)-20.67%

Income Statement

Revenue (ttm)67.91M
Revenue Per Share (ttm)1.04
Quarterly Revenue Growth (yoy)-95.20%
Gross Profit (ttm)326.13M
EBITDA -316.2M
Net Income Avi to Common (ttm)-304.28M
Diluted EPS (ttm)-5.01
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.1B
Total Cash Per Share (mrq)16.73
Total Debt (mrq)23.13M
Total Debt/Equity (mrq)1.57
Current Ratio (mrq)11.06
Book Value Per Share (mrq)22.43

Cash Flow Statement

Operating Cash Flow (ttm)-61.95M
Levered Free Cash Flow (ttm)43.93M